Monthly Archives: December 2014

Good question and something we have been working on. We have been searching host countries for “right to try” use scenarios. I have traveled to a number of potential host countries. Some frown upon experimental therapies that involve the patient … Continue reading →

Dear Mallory et.al. I think that you are spot on with your suggestion of “healthy lifestyle maintenance” but, would add: “and avoiding diseases & sickness”. The aging research community has pretty much all joined into the “Healthspan (Imperative) Campaign” initiated … Continue reading →

Welcome to the GRG@lists.ucla.edu mailing list! Welcome message from the GRG Executive Director Dear GRG Member, Thank you for joining the GRG Email Discussion Forum. A member can send a single E-mail message to a group of people. In turn, … Continue reading →

Dear Colleagues, your advice is of such high quality that only this group was able to provide. Please send us more of your ideas! We will compose a set of messages for rating and ask you to rate them, and only after … Continue reading →

Could the number of states initiating “right to try” programs for the Terminally ill be an avenue towards faster Human trials? There are a number of promising methods out there but nothing will happen unless testing in-vivo is tried. The … Continue reading →

Dear Daria, I think this is a really interesting and important approach. Following up from Johnny’s thoughts, it’s not clear to me whether your target audience will already have some knowledge of aging research, which of course will affect how … Continue reading →

Maybe the better way to frame the issue for broader society is to gauge whether people would support and/or partake in a treatment that was merely presented as giving them a greater chance to avoid frailty.  For example, a treatment … Continue reading →

Sierra Science has done a lot of work in this field and I appreciate and support Bill Andrews’ expertise in this area. He is the authority on the matter of telomerase. Werner syndrome and Progeria  are both accelerated aging diseases and are marked by short … Continue reading →

Hi Daria, Thanks for offering me an excuse to finally put together this list of surveys and perspectives about attitudes toward longevity and aging. It may prove useful.There are interesting results and possible insights hiding in these surveys. One of … Continue reading →

Dear Elliot, Thank you for your kind comments and your interest.  Please note that clinical trials are not the only way to increase healthspan.  For example, elimination of smoking for healthspan extension was justified by epidemiological studies, rather than by … Continue reading →